Health Care Sector
831 health care stocks ranked by market capitalization, page 3 of 17. Updated November 22, 2026.
Today
-0.41%Health Care stocks ranked 101–150
| # | Symbol | Company | Price | % Change | Volume | Market Cap |
|---|---|---|---|---|---|---|
| 101 | TGTX | TG Therapeutics Inc. | 63.34 | -2.37% | 2.09M | $9.57B |
| 102 | PODD | Insulet Corporation | 133.17 | -2.96% | 1.80M | $9.24B |
| 103 | HSIC | Henry Schein Inc. | 83.52 | -1.51% | 1.31M | $9.23B |
| 104 | KRYS | Krystal Biotech Inc. | 308.89 | -2.19% | 286.70K | $9.15B |
| 105 | SYRE | Spyre Therapeutics Inc. | 93.47 | -4.26% | 805.35K | $8.88B |
| 106 | GMED | Globus Medical Inc. Class A | 66.89 | -2.49% | 1.51M | $8.86B |
| 107 | MDGL | Madrigal Pharmaceuticals Inc. | 379.10 | -4.45% | 327.83K | $8.81B |
| 108 | PCVX | Vaxcyte Inc. | 55.39 | -5.09% | 1.91M | $8.77B |
| 109 | PRAX | Praxis Precision Medicines Inc. | 300.43 | -3.37% | 806.14K | $8.40B |
| 110 | SMMT | Summit Therapeutics Inc. | 9.95 | -5.87% | 7.21M | $7.96B |
| 111 | PTGX | Protagonist Therapeutics Inc. | 121.40 | -2.11% | 600.73K | $7.92B |
| 112 | RYTM | Rhythm Pharmaceuticals Inc. | 112.36 | -3.80% | 1.50M | $7.79B |
| 113 | OSCR | Oscar Health Inc. Class A | 24.73 | -5.50% | 6.60M | $7.68B |
| 114 | ALKS | Alkermes plc | 44.94 | -2.69% | 1.08M | $7.55B |
| 115 | KNSA | Kiniksa Pharmaceuticals International plc Class A | 93.90 | +0.38% | 545.14K | $7.38B |
| 116 | AMRX | Amneal Pharmaceuticals Inc. Class A | 21.12 | -1.26% | 1.67M | $7.36B |
| 117 | CHE | Chemed Corp | 548.59 | -0.50% | 159.44K | $7.11B |
| 118 | CGON | CG Oncology Inc. | 79.47 | -2.97% | 1.67M | $7.10B |
| 119 | CYTK | Cytokinetics Incorporated | 50.78 | -1.32% | 1.43M | $7.07B |
| 120 | TWST | Twist Bioscience Corporation | 103.32 | -7.44% | 3.38M | $7.04B |
| 121 | CORT | Corcept Therapeutics Incorporated | 63.62 | -2.09% | 1.09M | $6.96B |
| 122 | PACS | PACS Group Inc. | 43.67 | +1.49% | 964.37K | $6.93B |
| 123 | BLCO | Bausch + Lomb Corporation | 19.38 | -6.33% | 871.55K | $6.93B |
| 124 | AXSM | Axsome Therapeutics Inc. | 129.36 | -4.66% | 811.75K | $6.80B |
| 125 | LNTH | Lantheus Holdings Inc. | 102.10 | 0.00% | 1.07M | $6.68B |
| 126 | IMVT | Immunovant Inc. | 31.77 | -2.31% | 702.87K | $6.57B |
| 127 | MSA | MSA Safety Incorporated | 170.03 | -3.52% | 416.95K | $6.55B |
| 128 | ORKA | Oruka Therapeutics Inc. | 95.81 | -1.80% | 1.98M | $6.50B |
| 129 | TFX | Teleflex Incorporated | 161.58 | -1.11% | 654.99K | $6.41B |
| 130 | ABVX | Abivax SA ADR | 73.20 | -9.24% | 14.85M | $6.41B |
| 131 | IBRX | ImmunityBio Inc. | 6.02 | -8.37% | 10.57M | $6.40B |
| 132 | KOD | Kodiak Sciences Inc | 97.17 | -0.75% | 692.96K | $6.35B |
| 133 | MIRM | Mirum Pharmaceuticals Inc. | 96.13 | +0.65% | 1.06M | $6.28B |
| 134 | SUPN | Supernus Inc. | 28.61 | +0.92% | 2.83M | $5.94B |
| 135 | SRRK | Scholar Rock Holding Corporation | 48.13 | -4.45% | 2.08M | $5.87B |
| 136 | ARWR | Arrowhead Pharmaceuticals Inc. | 41.37 | -5.22% | 3.91M | $5.85B |
| 137 | LGND | Ligand Pharmaceuticals Incorporated | 286.85 | -0.03% | 259.77K | $5.74B |
| 138 | GRFS | Grifols S.A. ADR | 8.15 | -0.61% | 848.27K | $5.55B |
| 139 | RDNT | RadNet Inc. | 69.71 | +0.29% | 594.24K | $5.49B |
| 140 | HAE | Haemonetics Corporation | 120.16 | -0.17% | 382.95K | $5.47B |
| 141 | CON | Concentra Group Holdings Parent Inc. | 41.84 | +0.94% | 876.51K | $5.26B |
| 142 | LFST | LifeStance Health Group Inc. | 13.82 | +3.60% | 5.62M | $5.25B |
| 143 | BLTE | Belite Bio Inc ADR | 127.38 | -15.65% | 1.04M | $5.17B |
| 144 | MMSI | Merit Medical Systems Inc. | 84.34 | -0.08% | 560.27K | $5.05B |
| 145 | MANE | Veradermics Incorporated | 119.52 | -3.92% | 374.92K | $5.04B |
| 146 | CAI | Caris Life Sciences Inc. | 17.58 | -5.18% | 4.57M | $5.04B |
| 147 | LIVN | LivaNova PLC | 90.73 | -1.46% | 536.66K | $5.00B |
| 148 | LQDA | Liquidia Corporation | 54.43 | -3.88% | 1.69M | $4.90B |
| 149 | ERAS | Erasca Inc. | 13.61 | -4.29% | 11.07M | $4.78B |
| 150 | DNTH | Dianthus Therapeutics Inc. | 84.55 | -0.33% | 784.84K | $4.76B |
Prices as of Nov 22, 9:20 AM EST. Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer